Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Head and Neck Cancer

Free Subscription 27.04.2026 3 BMC Cancer 3 Cancer 2 Clin Cancer Res 4 Dis Esophagus 1 Head Neck 2 HNO 1 Hum Pathol 3 Int J Cancer 1 Int J Pediatr Otorhinolaryngol 2 Int J Radiat Oncol Biol Phys 4 J Clin Endocrinol Metab 1 J Clin Oncol 3 Oral Oncol 1 PLoS One 1 Surgery

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Cancer

1. EMMA R, Carota G, Partsinevelos K, Rust S, et al
   Effect of electronic cigarette aerosols on cisplatin resistance in head and neck cancer cells: a collaborative replication study.
   BMC Cancer. 2026 Apr 22. doi: 10.1186/s12885-026-16029.
   PubMed        
   
   
2. LIN X, Mo F, Zhang B, Pan Y, et al
   SARS-CoV-2 infection and its effects on toxicity and survival in non-metastatic nasopharyngeal carcinoma: a matched cohort study.
   BMC Cancer. 2026 Apr 22. doi: 10.1186/s12885-026-16038.
   PubMed        
   
   
3. HUANG G, Zhang L, Zhu J, He B, et al
   The impact of low skeletal muscle index and low muscle radiodensity on the prognosis of esophageal squamous cell carcinoma: a multi-center retrospective study in China (TIMES Study).
   BMC Cancer. 2026 Apr 21. doi: 10.1186/s12885-026-16048.
   PubMed        
   
   

   
   Cancer

4. INOUE T, Kono M, Kumai T, Obata K, et al
   Objective response rate predicts survival in recurrent or metastatic head and neck squamous cell carcinoma treated with immune checkpoint blockade but not with targeted therapy: A retrospective multicenter study.
   Cancer. 2026;132:e70429.
   PubMed         Abstract available
   
   
5. PATEL HV, Laird MC, Crone MD, Hranjec T, et al
   Disability-adjusted life-years from human papillomavirus-related oral cavity and pharynx cancers in US men, 2017-2021.
   Cancer. 2026;132:e70412.
   PubMed         Abstract available
   
   
6. KIM TM, Williamson SK, Papadopoulos KP, Hamid O, et al
   Fianlimab, a human lymphocyte activation gene-3 monoclonal antibody, in combination with cemiplimab: Tumor-specific expansion cohorts in advanced malignancies.
   Cancer. 2026;132:e70396.
   PubMed         Abstract available
   
   

   
   Clin Cancer Res

7. KONG Z, Liu Y, Lin YS, Li Z, et al
   Covalent FAPI Imaging-Guided Precision Surgery in Patients with Medullary Thyroid Carcinoma: A Phase II Clinical Trial.
   Clin Cancer Res. 2026 Apr 21:OF1-OF11. doi: 10.1158/1078-0432.CCR-25-3970.
   PubMed         Abstract available
   
   
8. LI S, Wu CC, Marczyk VR, Loberg MA, et al
   PRECISE: A prognostic thyrocyte-derived gene signature for papillary thyroid carcinoma.
   Clin Cancer Res. 2026 Apr 20. doi: 10.1158/1078-0432.CCR-25-4488.
   PubMed         Abstract available
   
   

   
   Dis Esophagus

9. WANG W, Ye L, Ruan K, Li H, et al
   Retrospective analysis of the optimal timing of immunotherapy in patients with advanced esophageal squamous cell carcinoma: a window of opportunity.
   Dis Esophagus. 2026;39:doag038.
   PubMed         Abstract available
   
   
10. VAN DER AA DC, Khatib R, Eshuis WJ, Daams F, et al
    Postoperative pulmonary complications after esophagectomy: risk factors and prediction model.
    Dis Esophagus. 2026;39:doag041.
    PubMed         Abstract available
    
    
11. LEE WC, Yang CC, Chen YC, Ho CH, et al
    Incidence and risk factors of short-term cardiovascular events in esophageal cancer patients undergoing radiotherapy.
    Dis Esophagus. 2026;39:doag037.
    PubMed         Abstract available
    
    
12. MATSUI K, Miyawaki Y, Suzuki Y, Furube T, et al
    Relationship between immune-related adverse events and long-term survival in patients treated with immune checkpoint inhibitors for unresectable advanced or recurrent esophageal cancer.
    Dis Esophagus. 2026;39:doag036.
    PubMed         Abstract available
    
    

    
    Head Neck

13. OULD ISMAIL AA, Pettus JR, Tafe LJ, Black CC, et al
    The Utility of Comprehensive Sampling in Cervical Lymph Node Dissection for Head and Neck Squamous Cell Carcinoma: Is More Better?
    Head Neck. 2026 Apr 23. doi: 10.1002/hed.70288.
    PubMed         Abstract available
    
    

    
    HNO

14. SANTER M, Schmit C, Schmutzler L, Dejaco D, et al
    [Prevention in oncological follow-up].
    HNO. 2026;74:297-302.
    PubMed         Abstract available
    
    
15. VAN BEEK MEF, Colotto U, Brockmann-Bauser M, Thuring CD, et al
    [A model for pretreatment assessment and prehabilitation in head and neck cancer : Presentation of the Zurich prehabilitation concept].
    HNO. 2026 Apr 22. doi: 10.1007/s00106-026-01760.
    PubMed         Abstract available
    
    

    
    Hum Pathol

16. OMI Y, Yamamoto T, Nagashima Y, Kurata A, et al
    Fascin expression is associated with aggressive clinicopathological features in parathyroid tumors.
    Hum Pathol. 2026;171:106074.
    PubMed         Abstract available
    
    

    
    Int J Cancer

17. FELDMANN N, Wichmann G, Dietz A, Pirlich M, et al
    Cohort study of standardized treatment pathways by multidisciplinary tumor board decision making in patients with salivary gland malignancies.
    Int J Cancer. 2026;158:3241-3251.
    PubMed         Abstract available
    
    
18. DE ABREU M, Kowalski LP, Lopez RM, Barul C, et al
    Risk of Head and Neck Cancer in Former Smokers by Subsite: A Multicenter Analysis From the INHANCE Consortium.
    Int J Cancer. 2026 Apr 21. doi: 10.1002/ijc.70497.
    PubMed         Abstract available
    
    
19. MARINHO MFP, da Fonseca Simas KB, Heras PV, da Cruz CAS, et al
    Effectiveness of Organized Strategies to Enhance Access to Preventive Oral Cancer Screening Among High-Risk Individuals in Brazil: A Randomized Clinical Trial in Primary Care.
    Int J Cancer. 2026 Apr 21. doi: 10.1002/ijc.70511.
    PubMed         Abstract available
    
    

    
    Int J Pediatr Otorhinolaryngol

20. MARRABLE L, Asairinachan A, Farwana M, Sutton L, et al
    Paediatric airway inflammatory myofibroblastic tumours: a decade of lessons from a quaternary centre.
    Int J Pediatr Otorhinolaryngol. 2026;204:112784.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

21. LUKENS JN, Riina MD, Weinstein G, MacDuffie E, et al
    Long-Term Results of a Phase II Clinical Trial of Radiation Volume and Dose De-intensification Following Transoral Robotic Surgery and Neck Dissection for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2026 Apr 16:S0360-3016(26)00590.
    PubMed         Abstract available
    
    
22. POON I, Karam I, Chin L, Galapin M, et al
    Implementation of Stereotactic Body Radiation Therapy SBRT for primary Primary Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2026;125:56-63.
    PubMed        
    
    

    
    J Clin Endocrinol Metab

23. WANG Z, Yang S, Li Y, Tian J, et al
    An Interpretable Machine Learning Model for Predicting Occult Central Lymph Node Metastasis in Papillary Thyroid Cancer.
    J Clin Endocrinol Metab. 2025 Dec 11:dgaf636. doi: 10.1210.
    PubMed         Abstract available
    
    
24. GARZA B, Calhoun J, Norman P, Cline N, et al
    Tumor-infiltrating T Lymphocytes Recognize Thyroid-specific and Neo-antigens in Follicular Cell-derived Thyroid Cancers.
    J Clin Endocrinol Metab. 2025 Nov 22:dgaf639. doi: 10.1210.
    PubMed         Abstract available
    
    
25. DOBNIG H, Amrein K
    Mid- to Long-term Outcomes After Single Radiofrequency Ablation of Non-Toxic and Toxic Thyroid Nodules.
    J Clin Endocrinol Metab. 2025 Nov 4:dgaf611. doi: 10.1210.
    PubMed         Abstract available
    
    
26. WASSERMAN JD, Isaza AR, Waguespack SG, Wassner AJ, et al
    The Landscape of Pediatric Differentiated Thyroid Carcinoma and Predictors of Invasive Disease: A CATC Study.
    J Clin Endocrinol Metab. 2026 Apr 22:dgag172. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

27. AWAN M, Caudell J, Wong S, Sumer B, et al
    Notably Off Key: Questioning the Clinical Benefit of Perioperative Immunotherapy for Resectable Head and Neck Squamous Cell Carcinoma After KEYNOTE-689.
    J Clin Oncol. 2026 Apr 22:JCO2501990. doi: 10.1200/JCO-25-01990.
    PubMed        
    
    

    
    Oral Oncol

28. GULMEZ E, Ozdemir AC, Al EA, Kara I, et al
    Evaluation of long-term outcomes of functional suprahyoid neck dissection in patients with early-stage lower lip cancer.
    Oral Oncol. 2026;177:107978.
    PubMed         Abstract available
    
    
29. YOKOTA T, Kiyota N, Kodaira T, Nishino H, et al
    Risk factors for aspiration pneumonia related to postoperative chemoradiotherapy for high-risk head and neck cancer: A supplementary analysis of a phase II/III JCOG1008 trial.
    Oral Oncol. 2026;177:107977.
    PubMed         Abstract available
    
    
30. CHEN W, Ye K
    Comment on "Prognostic significance of p16 and immune cell infiltration in recurrent/metastatic head and neck squamous cell carcinoma treated with PD-1 inhibition: a national DAHANCA cohort study".
    Oral Oncol. 2026;177:107972.
    PubMed        
    
    

    
    PLoS One

31. MACEDO LT, Ferrari VE, Dias Costa EF, Lourenco GJ, et al
    Pharmacogenetic strategies to mitigate cisplatin-induced ototoxicity in head and neck cancer: A cost-minimization analysis with the use of GSTP1 c.313A>G genotyping.
    PLoS One. 2026;21:e0345371.
    PubMed         Abstract available
    
    

    
    Surgery

32. YAMAMOTO M, Miyauchi A, Kihara M, Fujishima M, et al
    Postoperative risk stratification using calcitonin doubling rate in medullary thyroid carcinoma with biochemical persistent disease.
    Surgery. 2026;195:110208.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum